Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer
Surgery Today · 2023-11 · 53 (11) · 1236-1246
DOI: 10.1007/s00595-023-02701-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 14.06.2023. Verfasst von Yudai Miyashita und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cancer Survivors, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka University.
Abstract (Originalsprache)
Purpose
As the number of long-term survivors of pancreatic cancer is expected to increase thanks to recent advances in multidisciplinary treatment and earlier diagnoses of pancreatic cancer, we are likely to encounter more cases of postoperative pulmonary nodules. We analyzed the clinical course and prognosis of resection of pulmonary metastases from pancreatic cancer to clarify the prognostic implication of pulmonary metastasectomy for pancreatic cancer.
Method
We retrospectively analyzed 35 patients who underwent resection of lung metastases after pancreatic cancer surgery. Short- and long-term outcomes and factors associated with the prognosis were analyzed.
Results
The observation period was 20 (range, 1–101) months, with 3- and 5-year survival rates of 88.3% and 64.5% from pancreatectomy and 44.1% and 28.3% from lung resection, respectively. A univariate analysis revealed that a period from pancreatic cancer resection to pulmonary nodule shadow detection of < 15 months was associated with a significantly lower overall survival from pancreatic resection than a longer period. Conversely, histological type, stage, size of lung metastases, and resection technique were not associated with the overall survival.
Conclusion
A long-term prognosis may be expected in some cases with a disease-free interval of ≥ 15 months. Our findings suggest that the disease-free interval may influence the prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan.
- Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-15 Yamadaoka, Suita, Osaka, 565-0871, Japan. naokoose@thoracic.med.osaka-u.ac.jp.
- Department of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan.
- Department of Thoracic Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
- Department of Chest Surgery, Osaka Police Hospital, Osaka, Japan.
- Department of Thoracic Surgery, Sakai City Medical Center, Sakai, Osaka, Japan.
Förderung
- Osaka University
Zitieren
APA
Miyashita, Y., Ose, N., Okami, J., Takami, K., Sakamaki, Y., Ikeda, N., Hayakawa, M., Higashiyama, M., Kodama, K., Susaki, Y., Funakoshi, Y., Maeda, J., & Shintani, Y. (2023). Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer. Surgery Today, 53(11), 1236-1246. https://doi.org/10.1007/s00595-023-02701-0
Vancouver
Miyashita Y, Ose N, Okami J, Takami K, Sakamaki Y, Ikeda N, et al. Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer. Surgery Today. 2023;53(11):1236-1246. doi:10.1007/s00595-023-02701-0
BibTeX
@article{Miyashita2023,
author = {Miyashita, Yudai and Ose, Naoko and Okami, Jiro and Takami, Koji and Sakamaki, Yasushi and Ikeda, Naoki and Hayakawa, Masanobu and Higashiyama, Masahiko and Kodama, Ken and Susaki, Yoshiyuki and Funakoshi, Yasunobu and Maeda, Jun and Shintani, Yasushi},
title = {Outcomes of surgical resection for pulmonary metastasis from pancreatic cancer},
journal = {Surgery Today},
year = {2023},
volume = {53},
number = {11},
pages = {1236--1246},
doi = {10.1007/s00595-023-02701-0}
}
EUVIMED